167 related articles for article (PubMed ID: 36156210)
21. Bone marrow-derived mesenchymal stem/stromal cells in patients with acute myeloid leukemia reveal transcriptome alterations and deficiency in cellular vitality.
Zhang L; Chi Y; Wei Y; Zhang W; Wang F; Zhang L; Zou L; Song B; Zhao X; Han Z
Stem Cell Res Ther; 2021 Jun; 12(1):365. PubMed ID: 34174939
[TBL] [Abstract][Full Text] [Related]
22. Age-related inflammatory bone marrow microenvironment induces ineffective erythropoiesis mimicking del(5q) MDS.
Mei Y; Zhao B; Basiorka AA; Yang J; Cao L; Zhang J; List A; Ji P
Leukemia; 2018 Apr; 32(4):1023-1033. PubMed ID: 29263441
[TBL] [Abstract][Full Text] [Related]
23. Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?
Pleyer L; Valent P; Greil R
Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27355944
[TBL] [Abstract][Full Text] [Related]
24. Acute Myeloid Leukaemia in Its Niche: the Bone Marrow Microenvironment in Acute Myeloid Leukaemia.
Ladikou EE; Sivaloganathan H; Pepper A; Chevassut T
Curr Oncol Rep; 2020 Feb; 22(3):27. PubMed ID: 32048054
[TBL] [Abstract][Full Text] [Related]
25. The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants.
Rio-Machin A; Vulliamy T; Hug N; Walne A; Tawana K; Cardoso S; Ellison A; Pontikos N; Wang J; Tummala H; Al Seraihi AFH; Alnajar J; Bewicke-Copley F; Armes H; Barnett M; Bloor A; Bödör C; Bowen D; Fenaux P; Green A; Hallahan A; Hjorth-Hansen H; Hossain U; Killick S; Lawson S; Layton M; Male AM; Marsh J; Mehta P; Mous R; Nomdedéu JF; Owen C; Pavlu J; Payne EM; Protheroe RE; Preudhomme C; Pujol-Moix N; Renneville A; Russell N; Saggar A; Sciuccati G; Taussig D; Toze CL; Uyttebroeck A; Vandenberghe P; Schlegelberger B; Ripperger T; Steinemann D; Wu J; Mason J; Page P; Akiki S; Reay K; Cavenagh JD; Plagnol V; Caceres JF; Fitzgibbon J; Dokal I
Nat Commun; 2020 Feb; 11(1):1044. PubMed ID: 32098966
[TBL] [Abstract][Full Text] [Related]
26. Comparison of Outcomes of Myeloablative Allogeneic Stem Cell Transplantation for Pediatric Patients with Bone Marrow Failure, Myelodysplastic Syndrome and Acute Myeloid Leukemia with and without Germline GATA2 Mutations.
Hofmann I; Avagyan S; Stetson A; Guo D; Al-Sayegh H; London WB; Lehmann L
Biol Blood Marrow Transplant; 2020 Jun; 26(6):1124-1130. PubMed ID: 32088370
[TBL] [Abstract][Full Text] [Related]
27. Germline predisposition in myeloid neoplasms: Unique genetic and clinical features of GATA2 deficiency and SAMD9/SAMD9L syndromes.
Sahoo SS; Kozyra EJ; Wlodarski MW
Best Pract Res Clin Haematol; 2020 Sep; 33(3):101197. PubMed ID: 33038986
[TBL] [Abstract][Full Text] [Related]
28. Pediatric MDS and bone marrow failure-associated germline mutations in SAMD9 and SAMD9L impair multiple pathways in primary hematopoietic cells.
Thomas ME; Abdelhamed S; Hiltenbrand R; Schwartz JR; Sakurada SM; Walsh M; Song G; Ma J; Pruett-Miller SM; Klco JM
Leukemia; 2021 Nov; 35(11):3232-3244. PubMed ID: 33731850
[TBL] [Abstract][Full Text] [Related]
29. Coexistence of aberrant hematopoietic and stromal elements in myelodysplastic syndromes.
Abbas S; Kini A; Srivastava VM; M MT; Nair SC; Abraham A; Mathews V; George B; Kumar S; Venkatraman A; Srivastava A
Blood Cells Mol Dis; 2017 Jul; 66():37-46. PubMed ID: 28822917
[TBL] [Abstract][Full Text] [Related]
30. Functional Interference in the Bone Marrow Microenvironment by Disseminated Breast Cancer Cells.
Dhawan A; von Bonin M; Bray LJ; Freudenberg U; Pishali Bejestani E; Werner C; Hofbauer LC; Wobus M; Bornhäuser M
Stem Cells; 2016 Aug; 34(8):2224-35. PubMed ID: 27090603
[TBL] [Abstract][Full Text] [Related]
31. Bone Marrow Microenvironment as a Source of New Drug Targets for the Treatment of Acute Myeloid Leukaemia.
Skelding KA; Barry DL; Theron DZ; Lincz LF
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614005
[TBL] [Abstract][Full Text] [Related]
32. ERCC6L2 mitigates replication stress and promotes centromere stability.
Carnie CJ; Armstrong L; Sebesta M; Ariza A; Wang X; Graham E; Zhu K; Ahel D
Cell Rep; 2023 Apr; 42(4):112329. PubMed ID: 37014751
[TBL] [Abstract][Full Text] [Related]
33. ERCC6L2 promotes DNA orientation-specific recombination in mammalian cells.
Liu X; Liu T; Shang Y; Dai P; Zhang W; Lee BJ; Huang M; Yang D; Wu Q; Liu LD; Zheng X; Zhou BO; Dong J; Yeap LS; Hu J; Xiao T; Zha S; Casellas R; Liu XS; Meng FL
Cell Res; 2020 Sep; 30(9):732-744. PubMed ID: 32355287
[TBL] [Abstract][Full Text] [Related]
34. Bone marrow stromal cells from MDS and AML patients show increased adipogenic potential with reduced Delta-like-1 expression.
Weickert MT; Hecker JS; Buck MC; Schreck C; Rivière J; Schiemann M; Schallmoser K; Bassermann F; Strunk D; Oostendorp RAJ; Götze KS
Sci Rep; 2021 Mar; 11(1):5944. PubMed ID: 33723276
[TBL] [Abstract][Full Text] [Related]
35. Comparative Analysis of the Genetic Variants in Haematopoietic Stem/Progenitor and Mesenchymal Stem Cell Compartments in de novo Myelodysplastic Syndromes.
Bandara WMMS; Rathnayake AJIS; Neththikumara NF; Goonasekera HWW; Dissanayake VHW
Blood Cells Mol Dis; 2021 May; 88():102535. PubMed ID: 33461003
[TBL] [Abstract][Full Text] [Related]
36. Comparison of genetic and clinical aspects in patients with acute myeloid leukemia and myelodysplastic syndromes all with more than 50% of bone marrow erythropoietic cells.
Bacher U; Haferlach C; Alpermann T; Kern W; Schnittger S; Haferlach T
Haematologica; 2011 Sep; 96(9):1284-92. PubMed ID: 21606170
[TBL] [Abstract][Full Text] [Related]
37. Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia.
Kaszuba CM; Rodems BJ; Sharma S; Franco EI; Ashton JM; Calvi LM; Bajaj J
J Vis Exp; 2023 Nov; (201):. PubMed ID: 38009736
[TBL] [Abstract][Full Text] [Related]
38. Up-regulation of SPINT2/HAI-2 by Azacytidine in bone marrow mesenchymal stromal cells affects leukemic stem cell survival and adhesion.
Roversi FM; Cury NM; Lopes MR; Ferro KP; Machado-Neto JA; Alvarez MC; Dos Santos GP; Giardini Rosa R; Longhini AL; Duarte ADSS; Pericole FV; Favaro P; Yunes JA; Saad STO
J Cell Mol Med; 2019 Feb; 23(2):1562-1571. PubMed ID: 30484958
[TBL] [Abstract][Full Text] [Related]
39. First description of bone marrow failure syndrome in Spain caused by mutations in the ERCC6L2 gene.
Bandini P; Borràs N; Fernandez Mellid E; Martin-Fernandez L; Melero Valentín P; Comes N; Ramírez L; Cadahia Fernández P; Rodríguez Ruiz M; Perez Encinas MM; Vidal F; Corrales I
Br J Haematol; 2023 Nov; 203(4):e102-e107. PubMed ID: 37696499
[No Abstract] [Full Text] [Related]
40. Inherited thrombocytopenia and platelet disorders with germline predisposition to myeloid neoplasia.
Galera P; Dulau-Florea A; Calvo KR
Int J Lab Hematol; 2019 May; 41 Suppl 1():131-141. PubMed ID: 31069978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
